Guiling Li

1.1k total citations
38 papers, 523 citations indexed

About

Guiling Li is a scholar working on Oncology, Obstetrics and Gynecology and Reproductive Medicine. According to data from OpenAlex, Guiling Li has authored 38 papers receiving a total of 523 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Oncology, 9 papers in Obstetrics and Gynecology and 9 papers in Reproductive Medicine. Recurrent topics in Guiling Li's work include Cancer Immunotherapy and Biomarkers (15 papers), Endometrial and Cervical Cancer Treatments (7 papers) and Ovarian cancer diagnosis and treatment (7 papers). Guiling Li is often cited by papers focused on Cancer Immunotherapy and Biomarkers (15 papers), Endometrial and Cervical Cancer Treatments (7 papers) and Ovarian cancer diagnosis and treatment (7 papers). Guiling Li collaborates with scholars based in China, United States and India. Guiling Li's co-authors include Yumeng Wang, Congjian Xu, Congjian Xu, Wei Jiang, Wei Jiang, Chong Lu, Meng Zhang, Meng Zhang, Jing Peng and Mingxing Zhang and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Scientific Reports.

In The Last Decade

Guiling Li

37 papers receiving 514 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Guiling Li China 14 190 122 122 107 103 38 523
Sung‐Eun Namkoong South Korea 11 121 0.6× 186 1.5× 87 0.7× 101 0.9× 77 0.7× 17 471
Mario Uccello United Kingdom 12 171 0.9× 221 1.8× 41 0.3× 45 0.4× 135 1.3× 22 540
Mailinh Vu United States 4 121 0.6× 161 1.3× 47 0.4× 144 1.3× 113 1.1× 7 505
Ensong Guo China 12 139 0.7× 211 1.7× 81 0.7× 31 0.3× 81 0.8× 22 467
Walayat Shah Pakistan 13 239 1.3× 109 0.9× 210 1.7× 59 0.6× 13 0.1× 30 585
Alberto Serrano‐Olvera Mexico 8 141 0.7× 113 0.9× 25 0.2× 36 0.3× 80 0.8× 10 331
Nomonde Mbatani South Africa 7 80 0.4× 120 1.0× 18 0.1× 180 1.7× 80 0.8× 13 436
Guangming Cao China 13 52 0.3× 225 1.8× 139 1.1× 203 1.9× 54 0.5× 34 506
Antonios Koutras Greece 10 68 0.4× 205 1.7× 28 0.2× 54 0.5× 18 0.2× 51 479

Countries citing papers authored by Guiling Li

Since Specialization
Citations

This map shows the geographic impact of Guiling Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guiling Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guiling Li more than expected).

Fields of papers citing papers by Guiling Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guiling Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guiling Li. The network helps show where Guiling Li may publish in the future.

Co-authorship network of co-authors of Guiling Li

This figure shows the co-authorship network connecting the top 25 collaborators of Guiling Li. A scholar is included among the top collaborators of Guiling Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guiling Li. Guiling Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
He, Xiaozhou, Xuejun Zhang, Juan Liao, et al.. (2025). Triglycerides/high-density lipoprotein-cholesterol ratio outperforms traditional lipid indicators in predicting metabolic dysfunction-associated steatotic liver disease among U.S. adults. Frontiers in Endocrinology. 16. 1591241–1591241. 2 indexed citations
2.
Wu, Lingying, Xiaofan Li, Mei Feng, et al.. (2024). Efficacy and safety of enlonstobart (SG001), a PD-1 inhibitor in patients with PD-L1 positive recurrent/metastatic cervical cancer: A multicenter, single-arm, open-label, phase II study.. Journal of Clinical Oncology. 42(16_suppl). 5526–5526. 4 indexed citations
3.
4.
Zhai, You, Guiling Li, Wei Zhang, & Tao Jiang. (2024). PL02.1.A LOCOREGIONAL BI-SPECIFIC CAR-T CELLS TARGETING CD44 AND CD133 IN RECURRENT GLIOBLASTOMA: THE INTERIM RESULTS OF THE FIRST IN-HUMAN CLINICAL TRIAL. Neuro-Oncology. 26(Supplement_5). v1–v2. 1 indexed citations
5.
Peng, Jing, et al.. (2024). Combining cisplatin with Pinellia pedatisecta Schott lipid-soluble extract induces tumor immunogenic cell death in cervical cancer. Phytomedicine. 128. 155504–155504. 5 indexed citations
6.
Wang, Mengyao, et al.. (2024). Use of new-media health information among the elderly and its effect on their health and health management. BMC Public Health. 24(1). 2078–2078. 3 indexed citations
7.
Li, Guiling, et al.. (2023). Clinical Efficacy and Safety of Immunotherapy Retreatment in Metastatic Cervical Cancer: A Retrospective Study. OncoTargets and Therapy. Volume 16. 157–163. 8 indexed citations
8.
An, Jusheng, Xiu-Min Li, Jing Wang, et al.. (2023). Efficacy and safety of serplulimab plus nab-paclitaxel in previously treated patients with PD-L1–positive advanced cervical cancer: a phase II, single-arm study. Frontiers in Immunology. 14. 1142256–1142256. 10 indexed citations
9.
Peng, Jing, Qiyu Liu, Meng Zhang, et al.. (2023). Targeted Imaging of Endometriosis and Image-Guided Resection of Lesions Using Gonadotropin-Releasing Hormone Analogue-Modified Indocyanine Green. Molecular Imaging. 2023. 6674054–6674054. 3 indexed citations
10.
Chen, Yeshan, Ai Huang, Qin Yang, Jing Yu, & Guiling Li. (2022). Case report: A successful re-challenge report of GLS-010 (Zimberelimab), a novel fully humanized mAb to PD-1, in a case of recurrent endometrial cancer. Frontiers in Immunology. 13. 987345–987345. 8 indexed citations
11.
Peng, Jing, Fangfang Zhong, Mingxing Zhang, et al.. (2021). Clinical analysis of uterine intravenous leiomyomatosis: A retrospective study of 260 cases. Journal of obstetrics and gynaecology research. 47(12). 4357–4364. 13 indexed citations
12.
Fu, Yi‐Peng, Meng Zhang, Chong Lu, et al.. (2020). An Innovative Immune Score‐Based Prognostic Nomogram for Patients with Cervical Cancer. BioMed Research International. 2020(1). 8882576–8882576. 3 indexed citations
13.
Wang, Yumeng, Chong Lu, Sheng Yao, et al.. (2020). A lipid-soluble extract of Pinellia pedatisecta Schott orchestrates intratumoral dendritic cell-driven immune activation through SOCS1 signaling in cervical cancer. Journal of Ethnopharmacology. 267. 112837–112837. 17 indexed citations
14.
15.
Xiong, Liqin, Qiyu Liu, Qingqing Cai, et al.. (2017). Delineation of retroperitoneal metastatic lymph nodes in ovarian cancer with near-infrared fluorescence imaging. Oncology Letters. 14(3). 2869–2877. 8 indexed citations
16.
Wang, Jian, Haiping Tang, Yaping He, et al.. (2016). Epitomics: IgG-epitome decoding of E6, E7 and L1 proteins from oncogenic human papillomavirus type 58. Scientific Reports. 6(1). 34686–34686. 14 indexed citations
17.
Kang, Yu, Qingqing Cai, Mingxing Zhang, et al.. (2015). Identification of lymphatic metastasis-associated genes in a metastatic ovarian cancer cell line. Molecular Medicine Reports. 12(2). 2741–2748. 3 indexed citations
18.
Li, Guiling, et al.. (2010). Minimal deviation adenocarcinoma of the uterine cervix. International Journal of Gynecology & Obstetrics. 110(2). 89–92. 34 indexed citations
19.
20.
Li, Guiling, et al.. (1996). [The relationship of non-Hodgkin's lymphoma with P16 protein expression].. PubMed. 27(3). 254–7. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sung‐Eun Namkoong Breakdown of academic impact, for papers by Mario Uccello Breakdown of academic impact, for papers by Mailinh Vu Breakdown of academic impact, for papers by Ensong Guo Breakdown of academic impact, for papers by Walayat Shah Breakdown of academic impact, for papers by Alberto Serrano‐Olvera Breakdown of academic impact, for papers by Nomonde Mbatani Breakdown of academic impact, for papers by Guangming Cao Breakdown of academic impact, for papers by Antonios Koutras
Rankless by CCL
2026